Long-Term Survival with Primary Glioblastoma Multiforme: A Clinical Study in Bulgarian Patients
Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor with an extremely poor prognosis in spite of multimodal treatment approaches. The estimated median survival in cases with GBM is about 12–16 months. Those patients who survive ≧3 years after the initial diagnosis are...
Main Authors: | E. Naydenov, C. Tzekov, K. Minkin, S. Nachev, K. Romansky, V. Bussarsky |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2011-01-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/323432 |
Similar Items
-
Prognostic Factors of Survival in Glioblastoma Multiforme Patients—A Retrospective Study
by: Georgiana Șerban, et al.
Published: (2022-10-01) -
Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide
by: Alexandre Ciuffi Faustino, et al.
Published: (2020-09-01) -
A Case With Multicentric Glioblastoma Multiforme
by: Elif Tolgay, et al.
Published: (2008-08-01) -
Role of extent of resection on the survival of glioblastoma multiforme
by: Dipak Chaulagain, et al.
Published: (2023-06-01) -
Adjuvant uzatılmış temozolamid tedavisinin glioblastoma multiforme hastalarının sağkalımına etkisi
by: Berna YILDIRIM, et al.
Published: (2018-09-01)